Suprabasal expression of epidermal α2β1 and α3β1 integrins in skin treated with topical retinoic acid

British Journal of Dermatology

Volumn 138, Issue 1, 1998, Pages 29-36

  Hakkinen L ^b,c   Westermarck, J ^b,c   Johansson, N ^b,c   Aho, H ^b   Peltonen, J ^b   Heino, J ^b,c   Kahari V M ^a,b,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; RETINOIC ACID;

ADULT; ARTICLE; BASAL CELL; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EPIDERMIS HYPERPLASIA; HUMAN; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0031910531     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02023.x     Document Type: Article

References (38)

1. Heino J. Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int J Cancer 1996; 65: 717-22.
2. Larjava H, Peltonen J, Akiyama SK et al. Novel function for β1 integrins in keratinocyte cell-cell interactions. J Cell Biol 1990; 110: 803-15.
3. Peltonen J, Larjava H, Jaakkola S et al. Localization of integrin receptors for fibronectin, collagen and laminin in human skin: variable expression in basal and squamous cell carcinomas. J Clin Invest 1989; 84: 1916-23.
4. Hertle MD, Kubler MD, Leigh IM, Watt FM. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 1992; 89: 1892-901.
5. Larjava H, Salo T, Haapasalmi K et al. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 1993; 92: 1425-35.
6. Gailit J, Welch MP, Clark RAF. TGF-β1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 1994; 103: 221-7.
7. Kellner I, Konter U, Sterry W. Overexpression of extracellular matrix receptors (VLA-3, 5 and 6) on psoriatic keratinocytes. Br J Dermatol 1991; 125: 211-16.
8. Ralfkiaer E, Thomsen K, Vejlsgaard GL. Expression of a cell adhesion protein (VLA β) in normal and diseased skin. Br J Dermatol 1991; 124: 527-32.
9. Hertle MD, Jones PH, Groves RW et al. Integrin expression by human epidermal keratinocytes can be modulated by interferon-γ, transforming growth factor-β, tumor necrosis factor-α, and culture on a dermal equivalent. J Invest Dermatol 1995; 104: 260-5.
10. Fisher GJ, Esmann J, Griffiths EM et al. Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol 1991; 96: 699-707.
11. Tammi R, Ripelino JA, Margolis RU et al. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J Invest Dermatol 1989; 92: 326-32.
12. Varani J, Nickoloff BJ, Dixit VM et al. All-trans-retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion. J Invest Dermatol 1989; 93: 449-54.
13. Kim HJ, Bodgan NJ, D'Agostaro LJ et al. Effect of topical retinoic acids on the levels of collagen mRNA during the repair of UVB-induced dermal damage in the hairless mouse and the possible role of TGF-β as a mediator. J Invest Dermatol 1992; 98: 359-63.
14. Schwartz E, Kligman L. Topical tretinoin increases the tropoelastin and fibronectin content of photoaged hairless mouse skin. J Invest Dermatol 1995; 104: 518-22.
15. Rettig WJ, Dracopoli NC, Goetzger TA et al. Somatic cell genetic analysis of human cell surface antigens: chromosomal assignments and regulation of expression in rodent-human hybrid cells. Proc Natl Acad Sci USA 1984; 81: 6437-41.
16. Piscel KD, Hemler ME, Huang C et al. Use of monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol 1987; 138: 226-33.
17. Kantor RRS, Mattes MJ, Lloyd KO et al. Biochemical analysis of two cell surface glycoprotein complexes, very common antigen 1 and very common antigen 2. J Biol Chem 1987; 262: 15158-65.
18. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989; 109: 863-75.
19. Sonnenberg A, Hogervorst F, Osterop A, Veltman FEM. Identification and characterization of a novel antigen complex on mouse mammary tumor cells using a monoclonal antibody against platelet glycoprotein Ic. J Biol Chem 1988; 263: 14030-8.
20. Verrando P, Hsi BL, Yeh C-J et al. Monoclonal antibody GB3, a new probe for cell study of human basement membranes and hemidesmosomes. Exp Cell Res 1987; 170: 116-28.
21. Boyce S, Ham R. Cultivation, frozen storage, and clonal growth of normal human keratinocytes in serum free media. J Tissue Culture Methods 1985; 9: 83-93.
22. Boucamp P, Petrussevska RT, Breitkreuz D et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
23. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-19.
24. Heino J, Ignotz RA, Hemler ME et al. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 1989; 262: 380-8.
25. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem 1979; 18: 5294-9.
26. Argraves WS, Suzuki S, Arai H et al. Amino acid sequence of the human fibronectin receptor. J Cell Biol 1987; 105: 1183-90.
27. Takada Y, Hemler ME. The primary structure of the VLA-2/ collagen receptor α2 subunit (platelet GPIa): homology to other integrins and the presence of possible collagen binding domain. J Cell Biol 1989; 109: 397-407.
28. Tsuji T, Hakomori S-I, Osawa T. Identification of human galactoprotein β3, an oncogenic transformation-induced membrane glycoprotein, as VLA-3 alpha subunit: the primary structure of human integrin α3. J Biochem 1991; 109: 659-65.
29. Rosenthal DS, Griffiths CEM, Yuspa SH et al. Acute and chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol 1992; 98: 343-50.
30. Laurikainen L, Carey T, Peltonen J. The expression of α6 and β4 integrin genes are differentially regulated by all-trans-retinoic acid (RA) in cultured human keratinocytes. Arch Dermatol Res 1996; 288: 270-3.
31. Larjava H. Expression of β1 integrins in normal human keratinocytes. Am J Med Sci 1991; 301: 63-8.
32. Fisher GJ, Tavakkol A, Griffiths CEM et al. Differential modulation of transforming growth factor-β1 expression and mucin deposition by retinoic acid and sodium lauryl sulfate in human skin. J Invest Dermatol 1992; 98: 102-8.
33. Varani J, Perone P, Griffiths CEM et al. All-trans-retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest 1994; 94: 1747-56.
34. Chen S, Ostrowski J, Whiting G et al. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 1995; 104: 779-83.
35. Carroll JM, Romero MR, Watt FM. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995; 83: 957-68.
36. Saarialho-Kere UK, Kovacs SO, Pentland AP et al. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993; 92: 2858-66.
37. Riikonen T, Westermarck J, Koivisto L et al. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1 (I) gene expression. J Biol Chem 1995; 270: 13548-52.
38. Popp C, Kligman AM, Stoudemayer TJ. Pretreatment of photoaged forearm skin with topical tretinoin accelerates healing of full-thickness wounds. Br J Dermatol 1995; 132: 46-53.